Filing Details
- Accession Number:
- 0001209191-23-036087
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-09 20:00:30
- Reporting Period:
- 2023-06-08
- Accepted Time:
- 2023-06-09 20:00:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1828673 | Hcw Biologics Inc. | HCWB | Pharmaceutical Preparations (2834) | 825024477 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1866254 | Lee Flowers | C/O Hcw Biologics Inc 2929 N. Commerce Parkway Miramar FL 33025 | Svp Of Business Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-06-08 | 5,356 | $0.14 | 101,308 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2023-06-08 | 10,000 | $2.16 | 111,308 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2023-06-08 | 5,356 | $0.00 | 5,356 | $0.14 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
7,501 | 2029-09-18 | No | 4 | M | Direct |
Footnotes
- 20% of the total shares subject to the stock option grant vested on September 16, 2020; 20% of the total shares subject to the stock option grant vested on September 16, 2021; 25% of the total shares subject to the stock option grant will vest on September 16, 2022; and 35% of the total shares subject to the stock option grant will vest on September 16, 2023.